2018
DOI: 10.1016/j.cct.2018.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics

Abstract: ClinicalTrials.gov number NCT02128763.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
46
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 55 publications
(53 citation statements)
references
References 67 publications
0
46
0
Order By: Relevance
“…After the exclusion of 294 duplicate articles, 552 articles were assessed for eligibility. Finally, 15 records from 13 RCTs met the eligibility criteria [13,14,15,16,17,18,19,21,22,23,24,25,26,28]. The process of evidence selection is shown in Figure 1.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…After the exclusion of 294 duplicate articles, 552 articles were assessed for eligibility. Finally, 15 records from 13 RCTs met the eligibility criteria [13,14,15,16,17,18,19,21,22,23,24,25,26,28]. The process of evidence selection is shown in Figure 1.…”
Section: Resultsmentioning
confidence: 99%
“…For instance, DED was caused by a specific disease, surgery, or patients’ behavior. As we know, the PUFA effects upon the DED were various in etiology [27], and non-specific DED was most similar to real world populations [22,26]. The effect of PUFA on specific DED should be separated from this synthesis in the future.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Prior to study conduct, DED clinicians completed a certification program on the standardized procedures for assessing signs of DED. 21 Instillation of 2% fluorescein dye and 1% lissamine green dye was standardized by the use of an Eppendorf micropipette to instill 5 µL of dye into the inferior cul-de-sac. Measurements of TBUT began approximately 30 seconds after the addition of fluorescein dye.…”
Section: Methodsmentioning
confidence: 99%
“…A detailed description of the DREAM study design has previously been described. 9 Briefly, subjects needed to be ≥18 years with ocular symptoms related to DED for at least 6 months with the use of or a desire to use artificial tears. The patient's average score from the two visits on the OSDI needed to be between 22 and 80.…”
Section: Study Populationmentioning
confidence: 99%